Upcoming FDA decision · September 30, 2026
VNDA PDUFA date: FDA decision expected September 30, 2026
7 days to goVanda Pharmaceuticals Inc. (VNDA) →
The FDA is expected to decide on this application from Vanda Pharmaceuticals Inc. by the PDUFA target action date of September 30, 2026. For Non-24-hour sleep-wake disorder in the blind. sNDA filing. Extracted from SEC filing: 8-K
A PDUFA date is the FDA's target deadline to complete its review of a drug application — approval, a complete response letter (CRL), or an extension are all possible. What is a PDUFA date? This page is research information, not financial advice.
September 30
Target action date
NDA
Stage
Detected
Date confidence
—
FDA designations